Skip to main content

Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 2 | Breast Cancer Research

Figure 2

From: Association of CYP2D6metabolizer status with mammographic density change in response to tamoxifen treatment

Figure 2

Boxplot of percent mammographic density (PMD) change by CYP2D6 metabolizer status. Boxplot of percent mammographic density (PMD) change by CYP2D6 metabolizer status for subjects genotyped from whole blood and with baseline PMD ≥10% (n = 186). The maximum length of each whisker is 1.5 times the interquartile range. EM, extensive metabolizer; hetEM/IM, heterozygous extensive/intermediate; PM, poor metabolizer.

Back to article page